"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. . "
"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. iocarmic acid. this classification denotes an iodinated contrast dye with the molecular formula c24h20i6n4o8, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 82pb24k6tz, chemically known as 5,5-(tetramethylenebis(carbonylimino))bis(n-methyl-2,4,6-triiodoisophthalamic acid) but more generally known as iocarmic acid, which bears u.s. national institutes of health compound identifier 25229. the european medicines agency schedules iocarmic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08208mig. the term iocarmic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). the world health organization schedules iocarmic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(nc(=o)ccccc(=o)nc2c(i)c(c(i)c(c2i)c(=o)o)c(=o)nc)c(i)c(c(i)c1c(=o)nc)c(=o)o.. "
"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. iodoxamic acid. this classification denotes an iodinated contrast dye with the molecular formula c26h26i6n2o10, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier ns1y283hw4, chemically known as 4,7,10,13-tetraoxahexadecane-1,16-dioyl-bis(3-carboxytriiodoanilide) but more generally known as iodoxamic acid, which bears u.s. national institutes of health compound identifier 35740. the european medicines agency schedules iodoxamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08218mig. the term iodoxamic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). the world health organization schedules iodoxamic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(nc(=o)ccoccoccoccoccc(=o)nc2c(i)c(c(i)cc2i)c(=o)o)c(i)cc(i)c1c(=o)o.. "
"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. sodium ioxaglate. this classification denotes an iodinated contrast dye with the molecular formula c24h20i6n5o8.na, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier hq43cn02u9, chemically known as sodium n-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(n-methylacetamido)-5-(methylcarbamoyl)benzamido)acetamido)isophthalamate but more generally known as ioxaglate sodium, which bears u.s. national institutes of health compound identifier 50016. the european medicines agency schedules ioxaglate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02757mig. smiles: cc(=o)n(c)c1=c(c(=c(c(=c1i)c(=o)ncc(=o)nc2=c(c(=c(c(=c2i)c(=o)[o-])i)c(=o)ncco)i)i)c(=o)nc)i.[na+].. "
"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. technetium tc-99m or 99mtc. this classification denotes a radioisotope with the molecular structure tc, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier, 6ew75241vu chemically known as technetium, tc-99m, but more commonly known as technetium tc 99m, which bears u.s. national institutes of health compound identifier 6328391. the european medicines agency schedules technetium tc 99m in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15459mig.. "
"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. barium sulfate. a substance that is introduced into or around a structure and, because of the difference in absorption of x-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure. brand name liqui-coat hd, readi-cat, e. "
"medical imaging contrast media. this classification denotes medical imaging contrast media based on or infused with a radioactive fission product of uranium that bears the atomic symbol tc, the atomic number 43, and the atomic weight 98.91.. indocyanine green. indocyanine green for injection usp is a sterile, lyophilized green powder containing 25 mg of indocyanine green with no more than 5% sodium iodide. it is packaged with sterile water for injection, usp used to dissolve the indocyanine green. indocyanine green for injection usp is to be administered intravenously. indocyanine green for injection usp is indicated for determining cardiac output, hepatic function and liver blood flow and for ophthalmic angiography.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. . "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. aminohippurate sodium or aminohippuric acid. this classification denotes a diagnostic reagent, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier y79xt83bj9. the european medicines agency schedules aminohippuric acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12852mig. aminohippuric acid generally arises in the molecular formula c9h10n2o3. the term aminohippuric acid is a u.s. pharmacopeial convention designation. smiles: c1=cc(=cc=c1c(=o)ncc(=o)o)n.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. fluorescein. this classification denotes a contrast agent, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier tpy09g7xir. the european medicines agency schedules fluorescein sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13905mig. fluorescein generally arises in the molecular formula c20h12o5. the term fluorescein is an international nomenclature of cosmetic ingredients designation. smiles: o1c2c(c(c3c1cc(=o)cc3)c1c(cccc1)c(=o)o)ccc(o)c2.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. methacholine. this classification denotes a diagnostic reagent with the molecular formula c8h18no2.cl, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 0w5etf9m2k, chemically known as 1-propanaminium, 2-(acetyloxy)-n,n,n-trimethyl-, chloride but more generally known as methacholine chloride, which bears u.s. national institutes of health compound identifier 6114. the european medicines agency schedules methacholine chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08832mig. the term methacholine chloride is an international non-proprietary name. smiles: cc(c[n+](c)(c)c)oc(=o)c.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. metyrapone. this classification denotes a potassium-sparing diuretic with the molecular formula c14h14n2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier zs9kd92h6v, chemically known as 1,2-di-3-pyridyl-2-methyl-1-propanone but more generally known as metyrapone, which bears u.s. national institutes of health compound identifier 4174. the european medicines agency schedules metyrapone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08925mig. the term metyrapone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules metyrapone in its anatomical therapeutic chemical (atc) classification. metyrapone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=c(c(c1cccnc1)(c)c)c1cccnc1.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. radiopharmaceutical preparation kit. this classification denotes pre-packaged collections of tools indispenable to mixing and administering radioactive chemicals or radionuclide-marked diagnostic antibodies or contrast media.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. etanidazole. this classification denotes a radiosensitizing agent with the molecular formula c7h10n4o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 30dka3q1hl, chemically known as 2-nitroimidazole-1-acetamide, n-(2-hydroxyethyl)- but more generally known as etanidazole, which bears u.s. national institutes of health compound identifier 3276. the european medicines agency schedules etanidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07261mig. the term etanidazole is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27). etanidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=c(ncco)cn1c(ncc1)[n](=o)o.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. ibritumomab tiuxetan 90y. this classification denotes an immunoconjugate, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 4q52c550xk. the european medicines agency schedules ibritumomab tiuxetan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20031. ibritumomab tiuxetan generally arises in the molecular formula c23h32n5o10s. the term ibritumomab tiuxetan is an international non-proprietary name or inn (see world health organization inn reference publication, volume 14, no. 1, 2000, list 43.) smiles: none.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. iodine-125-fibrinogen. this classification denotes a pharmaceutical.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. alsactide. this classification denotes an amino acid, peptide, or protein with the molecular formula c99h155n29o21s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j0k70h3420, chemically known as 1-beta-alanine-17-(l-2,6-diamino-n-(4-aminobutyl)hexanamide)-alpha(sup 1-17)-corticotropin but generally known as alsactide, which bears us nih compound identifier 16129705. european medicines agency schedules alsactide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05374mig. the term alsactide is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules alsactide in its anatomical therapeutic chemical (atc) classification. alsactide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alsactide under hs 29371900 and sitc 54154. as of q4 2014, alsactide remains the us fda preferred term for this commodity. smiles: s(ccc(nc(=o)c(nc(=o)c(nc(=o)ccn)cc1ccc(o)cc1)co)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)ncc(=o)nc(c(=o)n1c(ccc1)c(=o)nc(c(c)c)c(=o)ncc(=o)nc(ccccn)c(=o)nc(ccccn)c(=o)nc(ccccn)c(=o)nccccn)ccccn)cc1c2c([nh]c1)cccc2)cccnc(=n)n)cc1ccccc1)cc1[nh]cnc1)ccc(.. "
"diagnostic agents and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes.. pentagastrin. this classification denotes a diagnostic reagent, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier ef0nx91490. european medicines agency schedules pentagastrin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09678mig. pentagastrin generally arises in the molecular formula c37h49n7o9s. the term pentagastrin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8.) pentagastrin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. . "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. medronate disodium/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. albumin/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx201. this va drug class (dx201) classifies this compound as belonging to the group imaging agents (in vivo) radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. ascorbic acid/methylene diphosphonic acid/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. barium sulfate/methylcellulose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx101. this va drug class (dx101) classifies this compound as belonging to the group non-ionic contrast media.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. diatrizoate/iodine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx102. this va drug class (dx102) classifies this compound as belonging to the group ionic contrast media.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. diatrizoate/iodipamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx102. this va drug class (dx102) classifies this compound as belonging to the group ionic contrast media.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. diatrizoate/lidocaine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx102. this va drug class (dx102) classifies this compound as belonging to the group ionic contrast media.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. disofenin/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. gluceptate/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. gluceptate/stannous chloride/tin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. methylene diphosphonic acid/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx201. this va drug class (dx201) classifies this compound as belonging to the group imaging agents (in vivo) radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. pentetate calcium trisodium/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx201. this va drug class (dx201) classifies this compound as belonging to the group imaging agents (in vivo) radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. pentetate pentasodium/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx201. this va drug class (dx201) classifies this compound as belonging to the group imaging agents (in vivo) radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. sodium hydroxymethane/stannous chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. stannous chloride/succimer. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx202. this va drug class (dx202) classifies this compound as belonging to the group non-imaging agents radiopharmaceuticals.. "
"combination contrast media, imaging agents, and radiopharmaceuticals. this classification denotes combination drugs and preparations that a) enable enhanced visualization of tissues; and/or b) provide radiation for radiotherapy and for diagnostic purposes. typical combination contrast media, imaging agent, and radiopharmaceutical constituents are albumin, ascorbic acid, barium sulfate, diatrizoate, disofenin, gallium citrate (ga-67), gluceptate, isosulfan blue, medronate disodium, methylene diphosphonic acid, pentetate calcium trisodium, pentetate pentasodium, sodium hydroxymethane, and stannous chloride.. diatrizoate meglumine or diatrizoate sodium. contrast medium used for gastroview.. "
"combination diagnostic agents. this classification denotes combination drugs and preparations which produce bio or physiological data or reactions which thereafter provide practitioners means to diagnose illness, hence the term diagnostics. typical combination diagnostic constituents are carbon monoxide, citric acid, cosyntropin, and sodium bicarbonate.. . "
"combination diagnostic agents. this classification denotes combination drugs and preparations which produce bio or physiological data or reactions which thereafter provide practitioners means to diagnose illness, hence the term diagnostics. typical combination diagnostic constituents are carbon monoxide, citric acid, cosyntropin, and sodium bicarbonate.. cosyntropin/mannitol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx900. this va drug class (dx900) classifies this compound as belonging to the group diagnostics, other.. "
"combination diagnostic agents. this classification denotes combination drugs and preparations which produce bio or physiological data or reactions which thereafter provide practitioners means to diagnose illness, hence the term diagnostics. typical combination diagnostic constituents are carbon monoxide, citric acid, cosyntropin, and sodium bicarbonate.. sodium bicarbonate/tartaric acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx900. this va drug class (dx900) classifies this compound as belonging to the group diagnostics, other.. "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. . "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. acetrizoic acid. this classification denotes a contrast agent with the molecular formula c9h6i3no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 24256bqv7m, chemically known as 3-(acetylamino)-2,4,6-triiodobenzoic acid but more generally known as acetrizoic acid, which bears u.s. national institutes of health compound identifier 6806. the european medicines agency schedules acetrizoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00256mig. the world health organization schedules acetrizoic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule acetrizoic acid under hs 29242995. smiles: ic1c(nc(=o)c)c(i)cc(i)c1c(=o)o.. "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. amidotrizoic acid or diatrizoate or diatrizoic acid. this classification denotes a contrast agent that practitioners often use (along with this commoditys ester) in x-ray and/or computed tomography (ct) liver studies, an agent with the molecular formula c11h9i3n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5uvc90j1lk, chemically known as 2,4,6-triiodo-3,5-diacetamidobenzoic acid but more generally known as diatrizoate, which bears u.s. national institutes of health compound identifier 2140. most nations schedule amidotrizoic acid or diatrizoate or diatrizoic acid under hs 29242995. smiles: cc(=o)nc1c(c(c(c(c1i)nc(=o)c)i)c(=o)[o-])i.[na+].. "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. methiodal. this classification denotes an iodinated contrast dye with the molecular formula ch2io3s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3880p18ubm, chemically known as monoiodomethanesulfonic acid, sodium salt but more generally known as methiodal, which bears u.s. national institutes of health compound identifier 31345. the european medicines agency schedules methiodal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03220mig. the term methiodal is an international non-proprietary name. the world health organization schedules methiodal in its anatomical therapeutic chemical (atc) classification. methiodal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methiodal under hs 29049020. smiles: ics(=o)(=o)o.[na].. "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. methiodal sodium. this classification denotes an iodinated contrast dye with the molecular formula ch2io3s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3880p18ubm, chemically known as monoiodomethanesulfonic acid, sodium salt but more generally known as methiodal, which bears u.s. national institutes of health compound identifier 31345. european medicines agency schedules methiodal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03220mig. the term methiodal is an international non-proprietary name. world health organization schedules methiodal in its anatomical therapeutic chemical (atc) classification. methiodal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methiodal sodium under hs 29049020 and sitc 51140. as of q4 2014, methiodal sodium remains the us fda preferred term for this commodity. methiodal sodium bears us nlm identifiers umls id c0142867 and nci concept code c83954. smiles: c(s(=o)(=o)[o-])i.[na+].. "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. metrizamide. this classification denotes a contrast agent with the molecular formula c18h22i3n3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rhh3w8f1co, chemically known as 3-acetylamino-5-n-methyl-acetylamino-2,4,6-triiodobenzoyl glucosamine but more generally known as metrizamide, which bears u.s. national institutes of health compound identifier 35734. the european medicines agency schedules metrizamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08921mig. the term metrizamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). the world health organization schedules metrizamide in its anatomical therapeutic chemical (atc) classification. metrizamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metrizamide under hs 29329970. smiles: ic1c(c(=o)nc2c(o)c(o)c(oc2o)co)c(i)c(nc(=o)c)c(i)c1n(c)c(=o)c.. "
"benzoic acid-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the molecular formula c7h6o2, chemically known as 3-acetamido-2,4,6-triiodobenzoic acid, and commonly known as benzoic acid, thus the term benzoic acid-based medical imaging agents, media, and tracers.. metrizoic acid. this classification denotes a contrast agent with the molecular formula c12h11i3n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cm1n99qr1m, chemically known as 3-(acetylamino)-5-(acetyl(methyl)amino)-2,4,6-triiodobenzoic acid but more generally known as metrizoic acid, which bears u.s. national institutes of health compound identifier 2528. the european medicines agency schedules metrizoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03276mig. the world health organization schedules metrizoic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule metrizoic acid under hs 29242995. smiles: cc(=o)nc1c(c(c(c(c1i)n(c)c(=o)c)i)c(=o)o)i.. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. . "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. fludarabine. this classification denotes a ribonucleotide reductase inhibitor and purine antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1x9vk9o1sc. the european medicines agency schedules fludarabine phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13897mig. fludarabine phosphate generally arises in the molecular formula c10h13fn5o7p. most nations schedule fludarabine under hs 29349990. the term fludarabine phosphate is a united states adopted name designation. smiles: p(=o)(occ1oc(n2c3nc(f)nc(n)c3nc2)c(o)c1o)(o)o.. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. fludeoxyglucose (18f) or fludeoxyglucose f-18. this classification denotes a fluorine-based medical imaging agent and tracer, commonly used in positron emission tomography (pet), a preparation which us fda regulates under unique ingredient identifier 0z5b2cjx4d. european medicines agency schedules fludeoxyglucose (18f) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07680mig. the term fludeoxyglucose (18f) is an international non-proprietary name (see who inn reference publication, volume 4, no. 3 1990, list 30.) fludeoxyglucose f-18 remains the us fda preferred term for this commodity. fludeoxyglucose (18f) bears us nlm identifiers umls id c0046056 and nci concept code c964. most nations, for tariff and trade purposes, schedule fludeoxyglucose (18f) under hs 28444000 and sitc 52519. smiles: c([c@h]([c@h]([c@@h]([c@h](c=o)[18f])o)o)o)o.. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. fluorodopa. this classification denotes a radio tracer used in pet analysis, with a molecular formula of c9h10fno4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2c598205qx. the european medicines agency schedules fluorodopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07719mig. most nations schedule fluorodopa under hs 28444030. smiles: c1=c(c(=cc(=c1o)o)f)cc(c(=o)o)n.. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. fluorouracil. this classification denotes a thymidylate synthase inhibitor and pyrimidine antagonist with the molecular formula c4h3fn2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u3p01618rt, chemically known as 2,4-dioxo-5-fluoropyrimidine but more generally known as fluorouracil, which bears u.s. national institutes of health compound identifier 3385. the european medicines agency schedules fluorouracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07721mig. the term fluorouracil is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules fluorouracil in its anatomical therapeutic chemical (atc) classification. fluorouracil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fluorouracil under hs 29335995. smiles: fc1c(=o)[nh]c(=o)[nh]c1.. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. sodium fluoride. this classification denotes a reagent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8zyq1474w7. the european medicines agency schedules sodium fluoride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15285mig. sodium fluoride generally arises in the molecular formula fna. the term sodium fluoride is a united states homeopathic pharmacopoeia name designation. most nations schedule sodium fluoride under hs 28261900. smiles: [f-].[na+].. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. sulfur hexafluoride. this classification denotes a contrast agent with the molecular formula f6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ws7lr3i1d6, chemically known as sulfur fluoride (sf6), (oc-6-11)- but more generally known as sulfur hexafluoride, which bears u.s. national institutes of health compound identifier 17358. the european medicines agency schedules sulfur hexafluoride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15925mig. the world health organization schedules sulfur hexafluoride in its anatomical therapeutic chemical (atc) classification. most nations schedule sulfur hexafluoride under hs 28111990. smiles: s(f)(f)(f)(f)(f)f.. "
"fluorine-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element and halogen with the symbol f and atomic number 9 known as fluorine, and isotopes thereof, thus the term fluorine-based medical imaging agents, media, and tracers.. tft or trifluorothymidine or trifluridine. this classification denotes a pyrimidine antagonist with the molecular formula c10h11f3n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rmw9v5rw38, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-ribofuranosyl)-5-(trifluoromethyl)- but generally known as trifluridine, which bears us nih compound identifier 6256. european medicines agency schedules trifluridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11291mig. the term trifluridine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules trifluridine in its anatomical therapeutic chemical (atc) classification. trifluridine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: c1c(c(oc1n2c=c(c(=o)nc2=o)c(f)(f)f)co)o.. "
"fluorocarbon-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on organofluorine compounds with the base formula cxfy, compounds commonly called fluorocarbons, thus the term fluorocarbon-based medical imaging agents, media, and tracers.. . "
"fluorocarbon-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on organofluorine compounds with the base formula cxfy, compounds commonly called fluorocarbons, thus the term fluorocarbon-based medical imaging agents, media, and tracers.. perflenapent or perfluoropentane. this classification denotes a contrast agent, generally used in radiography, with the molecular structure c5f12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 483au1y5cz chemically known as pentane, dodecafluoro-, but more commonly known as dodecafluoropentane, which bears u.s. national institutes of health compound identifier 12675. the european medicines agency schedules dodecafluoropentane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12493mig. most nations schedule perflenapent or perfluoropentane under hs 29033900. smiles: fc(f)(c(f)(f)c(f)(f)f)c(f)(f)c(f)(f)f.. "
"fluorocarbon-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on organofluorine compounds with the base formula cxfy, compounds commonly called fluorocarbons, thus the term fluorocarbon-based medical imaging agents, media, and tracers.. perflubron or perfluorooctyl bromide. this classification denotes a diagnostic reagent with the molecular formula c8brf17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q1d0q7r4d9, chemically known as 1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane but more generally known as perflubron, which bears u.s. national institutes of health compound identifier 9873. the european medicines agency schedules perflubron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09721mig. the term perflubron is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32). the world health organization schedules perflubron in its anatomical therapeutic chemical (atc) classification. perflubron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule perflubron or perfluorooctyl bromide under hs 29034700. smiles: brc(f)(f)c(f)(f)c(f)(f)c(f)(f)c(f)(f)c(f)(f)c(f)(f)c(f)(f)f.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. . "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadobenic acid. this classification denotes a gadolinium-chelate with the molecular formula c22h26n3o11.gd.2h, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 15g12l5x8k, chemically known as gadolinate(2-), (4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)-n5,n8,n11,o4,o5,o8,o11,o13)-, dihydrogen but more generally known as gadobenic acid, which bears u.s. national institutes of health compound identifier 105124. the european medicines agency schedules gadobenic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07860mig. the world health organization schedules gadobenic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule gadobenic acid under hs 28469000. smiles: [gd]12[n](cc[n]1(c(cocc1ccccc1)c(=o)o)cc(=o)o)(cc[n]2(cc(=o)o)cc(=o)o)cc(=o)o.[h].[h].. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadobutrol. this classification denotes a gadolinium-chelate with the molecular formula c18h31n4o9.gd, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1bj477io2l, chemically known as gadolinium, (10-(2,3-dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n1,n4,n7,n10,o1,o4,o7)- but more generally known as gadobutrol, which bears u.s. national institutes of health compound identifier 72057. the european medicines agency schedules gadobutrol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07861mig. the term gadobutrol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32). the world health organization schedules gadobutrol in its anatomical therapeutic chemical (atc) classification. gadobutrol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gadobutrol under hs 28469000. smiles: [gah3].oc(c(n1ccn(ccn(ccn(cc1)cc(=o)o)cc(=o)o)cc(=o)o)co)co.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadodiamide. this classification denotes a gadolinium-chelate with the molecular formula c16h26gdn5o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84f6u3j2r6, chemically known as gadolinium, aqua(5,8-bis(carboxymethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-))-, hydrate but more generally known as gadodiamide, which bears u.s. national institutes of health compound identifier 60754. the european medicines agency schedules gadodiamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07862mig. the term gadodiamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 5, no. 3 1991, list 31). the world health organization schedules gadodiamide in its anatomical therapeutic chemical (atc) classification. gadodiamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: [gd].oc(=o)cn(ccn(cc(=o)nc)cc(=o)o)ccn(cc(=o)nc)cc(=o)o.o. most nations schedule gadodiamide under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadodiamide hydrate. this classfication denotes a gadolinium-chelate with the molecular formula c16h26n5o8.gd.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0rpe15qpl0, chemically known as aqua(n-n-bis(2-((carboxymethyl)((methylcarbamoyl)methyl)amino)ethyl)glycinato(3-))gadolinium hydrate, but more generally known as gadodiamide hydrate, which bears u.s. national institutes of health compound identifier 60754. european medicines agency schedules gadodiamide hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07862mig. most nations, for tariff purposes, schedule gadodiamide hydrate under hs 28469000. smiles: cnc(=o)cn(ccn(ccn(cc(=o)nc)cc(=o)[o-])cc(=o)[o-])cc(=o)[o-].o.o.o.[gd+3].. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadofosveset. this classification denotes a gadolinium-chelate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e65rw73phs. the european medicines agency schedules gadofosveset in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25385. gadofosveset generally arises in the molecular formula c33h38n3o14p.3h+.gd. the term gadofosveset is an international non-proprietary name or inn (see world health organization inn reference publication, volume 15 no. 1, 2001, list 45.) most nations schedule gadofosveset under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadofosveset trisodium. this classification denotes a gadolinium-chelate with the molecular formula c33h38n3o14p.gd.3na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xm33q67uvh, chemically known as gadolinate(3-), (((4r)-4-(bis((carboxy-kappao)methyl)amino-kappan)-6,9-bis((carboxy-kappao)methyl)-1-((4,4-diphenylcyclohexyl)oxy)-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-oic acid-kappan6,kappan9,kappao11) 1-oxidato(6-))-, trisodium but more generally known as gadofosveset trisodium, which bears u.s. national institutes of health compound identifier 158440. european medicines agency schedules gadofosveset trisodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21051. most nations schedule gadofosveset trisodium under hs 28469000 and sitc 52595. as of q4 2014, gadofosveset trisodium remains the us fda preferred term for this commodity. gadofosveset trisodium bears us nlm identifiers umls id c1433439 and nci concept code c81057. smiles: c1ccc(cc1)c2(ccc(cc2)op(=o)([o-])oc[c@@h](cn(ccn(cc(=o)[o-])cc(=o)[o-])cc(=o)[o-])n(cc(=o)[o-])cc(=o)[o-])c3ccccc3.o.[na+].[na+].[na+].[gd+3].. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadolinium. this classificaiton denotes a nonionic structural analog used as a paramagnetic contrast medium in magnetic resonance imaging. brand name omniscan most nations schedule gadolinium under hs 28053000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadopentetic acid. this classification denotes a gadolinium-chelate with the molecular formula c14h18n3o10.2h+.gd, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k2i13dr72l, chemically known as gadolinate(2-), (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen but more generally known as gadopentetic acid, which bears u.s. national institutes of health compound identifier 157429. the european medicines agency schedules gadopentetic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07864mig. the world health organization schedules gadopentetic acid in its anatomical therapeutic chemical (atc) classification. smiles: [gd].oc(=o)cn(ccn(cc(=o)o)cc(=o)o)ccn(cc(=o)o)cc(=o)o.[h].[h]. most nations schedule gadopentetic acid under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadoteric acid. this classification denotes a gadolinium contrast media with the molecular formula c16h24n4o8.h+.gd, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qvf9y6955w, chemically known as hydrogen (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-))gadolinate(1-). but more generally known as gadoteric acid, which bears u.s. national institutes of health compound identifier 3085828. the european medicines agency schedules gadoteric acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07865mig. the world health organization schedules gadoteric acid in its anatomical therapeutic chemical (atc) classification. smiles: [gd].oc(=o)cn1ccn(ccn(ccn(cc1)cc(=o)o)cc(=o)o)cc(=o)o. most nations schedule gadoteric acid under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadoteridol. this classification denotes a gadolinium-chelate with the molecular formula c17h29gdn4o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0199mv609f, chemically known as 1,4,7,10-tetraazacyclododecan-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-, gadolinium complex but more generally known as gadoteridol, which bears u.s. national institutes of health compound identifier 60714. the european medicines agency schedules gadoteridol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07866mig. the term gadoteridol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 5, no. 3 1991, list 31). the world health organization schedules gadoteridol in its anatomical therapeutic chemical (atc) classification. gadoteridol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: [gd].oc(cn1ccn(ccn(ccn(cc1)cc(=o)o)cc(=o)o)cc(=o)o)c. most nations schedule gadoteridol under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadoversetamide. this classification denotes a gadolinium-chelate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rlm74t3z9d. the european medicines agency schedules gadoversetamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07867mig. gadoversetamide generally arises in the molecular formula c20h34gdn5o10. the term gadoversetamide is an international non-proprietary name or inn. gadoversetamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: [gd].oc(=o)cn(ccn(cc(=o)nccoc)cc(=o)o)ccn(cc(=o)nccoc)cc(=o)o. most nations schedule gadoversetamide under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadoxetic acid. this classification denotes a gadolinium-chelate and contrast agent (especially deployed liver ct studies), a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3qja87n40s. the european medicines agency schedules gadoxetic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07868mig. gadoxetic acid generally arises in the molecular formula c23h30gdn3o11. the term gadoxetic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 9, no. 3, 1995, list 35.) smiles: [gd]12[n](cc([n]1(cc(=o)o)cc(=o)o)cc1ccc(occ)cc1)(cc[n]2(cc(=o)o)cc(=o)o)cc(=o)o.[h].[h]. most nations schedule gadoxetic acid under hs 28469000.. "
"gadolinium-based medical imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element that bears symbol gd and atomic number 64, called gadolinium, and isotopes thereof, thus the term gadolinium-based medical imaging agents, media, and tracers.. gadoterate meglumine. a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (mri) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (bbb) and/or abnormal vascularity.. "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. . "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. indium 111 capromab pendetide. this classification denotes an immunoconjugate with the molecular formula c32h43n7o14.2h+.in, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 03mz53x1ys. the term indium 111 capromab pendetide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13 no. 1, 1999, list 41.).. "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. indium in 111 oxyquinoline. this classification denotes a radioconjugate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lgx9ol562t. european medicines agency schedules indium in 111 oxyquinoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14205mig. indium in 111 oxyquinoline generally arises in the molecular formula 3c9h6no.in. the term indium in 111 oxyquinoline is a united states adopted name designation. smiles: c1=cc2=c(c(=c1)[o-])n=cc=c2.c1=cc2=c(c(=c1)[o-])n=cc=c2.c1=cc2=c(c(=c1)[o-])n=cc=c2.[in+3].\\.. "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. indium in 111 antiovariumcarcinoma antibody. this classification denotes a radioconjugate, a preparation that world health organization schedules in its anatomical therapeutic chemical (atc) classification.. "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. indium in 111 pentetic acid or indium (111in) pentetic acid. this classification denotes a radioconjugate with the molecular formula c14h18n3o10.2h, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5k3up561ax, a preparation that world health organization schedules in its anatomical therapeutic chemical (atc) classification.. "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. indium in 111 pentetreotide or indium (111in) pentetreotide. this classification denotes a radioconjugate with the molecular formula c63h83n13o19s2.h+.in (a diethylenetriaminopentaacetic (dtpa) conjugate of the human hormone somatostatin peptide analogue [octreotide]), a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m312jj6z32, a preparation that world health organization schedules in its anatomical therapeutic chemical (atc) classification. indium in 111 satumomab pendetide bears us nlm nci c1672.. "
"indium-based medical imaging agents and media. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol in and atomic number 49, called indium, and isotopes thereof, thus the term indium-based medical imaging agents and media.. indium in 111 satumomab pendetide or indium (111in) satumomab pendetide. this classification denotes a radioconjugate with the molecular formula c32h43n7o14.2h+.in, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7v9926378a, a preparation that world health organization schedules in its anatomical therapeutic chemical (atc) classification. indium in 111 satumomab pendetide bears us nlm nci c1469.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. . "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. adipiodone or iodipamide. this classification denotes an iodinated contrast dye (especially used in liver ct studies) with the molecular formula c20h14i6n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tkq858a3vw, chemically known as 3,3-(adipoyldiimino)bis(2,4,6-triiodobenzoic acid) but more generally known as adipiodone, which bears u.s. national institutes of health compound identifier 3739. adipiodone most often comes in forms base and meglumine. european medicines agency schedules adipiodone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05273mig. the term adipiodone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules adipiodone in its anatomical therapeutic chemical (atc) classification. adipiodone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule adipiodone or iodipamide under hs 29242995. adipiodone or iodipamide bears us nlm identifiers umls id c0021971 and nci concept code c61791. smiles: ic1c(nc(=o)ccccc(=o)nc2c(i)c(c(i)cc2i)c(=o)o)c(i)cc(i)c1c(=o)o.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. calcium iopodate. this classification denotes a diagnostic reagent with the molecular formula 2c12h12i3n2o2.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50s7w5m9zz. the term calcium iopodate is a u.s. fda designation. smiles: ic1c(ccc(=o)o)c(i)cc(i)c1/n=c/n(c)c.ic1c(ccc(=o)o)c(i)cc(i)c1/n=c/n(c)c.[ca]. most nations schedule calcium iopodate under hs 29252900.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. diodone or iodopyracet. this classification denotes an iodinated contrast dye with the molecular formula c7h5i2no3.c4h11no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ztk4026yj5, chemically known as 3,5-diiodo-4-pyridone-n-acetic acid, diethanolamine salt but more generally known as diodone, which bears u.s. national institutes of health compound identifier 9303. the european medicines agency schedules diodone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07197mig. the term diodone is an international non-proprietary name. the world health organization schedules diodone in its anatomical therapeutic chemical (atc) classification. diodone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1cn(cc(=o)o)cc(i)c1=o.occ[nh2]cco. most nations schedule diodone or iodopyracet under hs 29333999.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ethiodized oil or ethiodol or or lipiodol. this classification denotes an ethyl ester of iodinated fatty acid of poppyseed oil. it contains 37% organically bound iodine and has been used as a diagnostic aid (radiopaque medium) and as an antineoplastic agent when part of the iodine is 131-i, a preparation with the molecular formula c20h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kzw0r0686q, chemically known as (3s,8r,9s,10r,13s,14s,17r)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol, but more generally known as ethiodized oil or ethinodiol or etynodiol, which bears u.s. national institutes of health compound identifier 14687. the european medicines agency schedules ethiodized oil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13737mig. the term ethiodized oil is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). etynodiol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc12ccc3c(c1ccc2(c#c)o)ccc4=cc(ccc34)o. most nations schedule ethiodized oil or ethiodol or or lipiodol under hs 28444030.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iobenguane. this classification denotes an iodinated contrast dye with the molecular formula c8h10in3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 35mrw7b4ad, chemically known as guanidine, ((3-iodophenyl)methyl)- but more generally known as iobenguane, which bears u.s. national institutes of health compound identifier 60860. the european medicines agency schedules iobenguane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32630. iobenguane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1cc(c/n=c(/n)n)ccc1. smiles: ic1cc(c/n=c(/n)n)ccc1. most nations schedule iobenguane under hs 28444030.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iobenguane sulfate. this classfication denotes an iodinated contrast dye with the molecular formula 2c8h10in3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s8i0922465, chemically known as guanidine, n-((3-iodophenyl)methyl)-, sulfate (2:1), but more generally known as iobenguane sulfate, which bears u.s. national institutes of health compound identifier 2759362. european medicines agency schedules iobenguane sulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32630. most nations, for tariff purposes, schedule iobenguane sulfate under hs 28444030. smiles: c1cc(cc(c1)i)cnc(=n)n.c1cc(cc(c1)i)cnc(=n)n.os(=o)(=o)o.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iobenzamic acid. this classification denotes a triiodobenzoic acid with the molecular formula c16h13i3n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f72uwg2swk, chemically known as 3-((3-amino-2,4,6-triiodobenzoyl)phenylamino)propionic acid but more generally known as iobenzamic acid, which bears u.s. national institutes of health compound identifier 18377. the european medicines agency schedules iobenzamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08204mig. the world health organization schedules iobenzamic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(c(=o)n(ccc(=o)o)c2ccccc2)c(i)cc(i)c1n. most nations schedule iobenzamic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iobitridol. this classification denotes an iodinated contrast dye with the molecular formula c20h28i3n3o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 182ech14uh, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((5-hydroxy-2-(hydroxymethyl)-1-oxopropyl)amino)-2,4,6-triiodo-n,n-dimethyl- but more generally known as iobitridol, which bears u.s. national institutes of health compound identifier 65985. the european medicines agency schedules iobitridol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08205mig. the term iobitridol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 7, no3, 1993, list 33). the world health organization schedules iobitridol in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(c(=o)n(cc(o)co)c)c(i)c(nc(=o)c(co)co)c(i)c1c(=o)n(cc(o)co)c. most nations schedule iobitridol under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iocarmate or iocarmic acid or iocarmate meglumine. this classification denotes an iodinated contrast dye with the molecular formula c24h20i6n4o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 82pb24k6tz, chemically known as 5,5-(tetramethylenebis(carbonylimino))bis(n-methyl-2,4,6-triiodoisophthalamic acid) but more generally known as iocarmic acid, which bears u.s. national institutes of health compound identifier 25229. the european medicines agency schedules iocarmic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08208mig. the term iocarmic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). the world health organization schedules iocarmic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(nc(=o)ccccc(=o)nc2c(i)c(c(i)c(c2i)c(=o)o)c(=o)nc)c(i)c(c(i)c1c(=o)nc)c(=o)o. most nations schedule iocarmate or iocarmic acid or iocarmate meglumine under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iocetamic acid. this classification denotes an iodinated contrast dye with the molecular formula c12h13i3n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fa675q0e3e, chemically known as 3-(acetyl-(3-amino-2,4,6-triiodophenyl)amino)-2-methylpropanoic acid but more generally known as iocetamic acid, which bears u.s. national institutes of health compound identifier 27648. the european medicines agency schedules iocetamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08209mig. the term iocetamic acid is an international non-proprietary name. the world health organization schedules iocetamic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule iocetamic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iodamide or iodamide meglumine. this classification denotes an iodinated contrast dye with the molecular formula c12h11i3n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4rii332o0r, chemically known as 3-acetylaminomethyl-5-acetylamino-2,4,6-triiodobenzoic acid but more generally known as iodamide, which bears u.s. national institutes of health compound identifier 3723. the european medicines agency schedules iodamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08210mig. the world health organization schedules iodamide in its anatomical therapeutic chemical (atc) classification. iodamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(=o)ncc1=c(c(=c(c(=c1i)c(=o)o)i)nc(=o)c)i. most nations schedule iodamide or iodamide meglumine under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iodinated i-125 human serum albumin or jeanatope. this classification denotes a biological-based radiopharmaceutical diagnostic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 68wqq3n9ti. smiles: none. most nations schedule iodinated i-125 human serum albumin or jeanatope under hs 28444030.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iodixanol. this classification denotes a dimeric, sterile, pyrogen-free, colorless to pale yellow solution isosmolar, nonionic, water-soluble, radiographic contrast medium that practitioners often deploy in x-ray and/or computed tomography (ct) liver studies (especially iodixanol liposomes). bears us nlm identifiers umls id c0063757 and nci concept code c65931. most nations schedule iodixanol under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iodoxamate or iodoxamate meglumine or iodoxamic acid. this classification denotes an iodinated contrast dye with the molecular formula c26h26i6n2o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ns1y283hw4, chemically known as 4,7,10,13-tetraoxahexadecane-1,16-dioyl-bis(3-carboxytriiodoanilide) but more generally known as iodoxamic acid, which bears u.s. national institutes of health compound identifier 35740. the european medicines agency schedules iodoxamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08218mig. the term iodoxamic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). the world health organization schedules iodoxamic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(nc(=o)ccoccoccoccoccc(=o)nc2c(i)c(c(i)cc2i)c(=o)o)c(i)cc(i)c1c(=o)o. most nations schedule iodoxamate or iodoxamate meglumine or iodoxamic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iofendylate or iophendylate. this classification denotes an iodinated contrast dye, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2990i809yh. the european medicines agency schedules iofendylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08219mig. iofendylate generally arises in the molecular formula c19h29io2. the term iofendylate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5.) iofendylate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ccoc(=o)ccccccccc(c)c1=cc=c(c=c1)i. most nations schedule iofendylate or iophendylate under hs 29163900.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iofetamine i-123. this classification denotes a contrast media with the molecular formula c12h18in, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) lv23b78ijc, chemically known as 1-(4-iodanylphenyl)-n-propan-2-ylpropan-2-amine but more generally known as iofetamine i-123, which bears u.s. national institutes of health compound identifier 156375. the term iofetamine i-123 is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24.) european medicines agency schedules iofetamine i-123 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08220mig. world health organization schedules iofetamine i-123 in its anatomical therapeutic chemical (atc) classification. iofetamine i-123 is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule iofetamine i-123 under hs 28444030 and sitc 52519. as of q4 2014, iofetamine i-123 remains the us fda preferred term for this commodity. smiles: cc(c)nc(c)cc1=cc=c(c=c1)i.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioflupane 123i. this classification denotes a radiopharmaceutical compound with the molecular formula c18h23fino2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3mm99t8r5q, more generally known as ioflupane (123i). european medicines agency schedules ioflupane (123i) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08221mig. the term ioflupane (123i) is an international non-proprietary name or inn.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioglicic acid. this classification denotes an iodinated contrast dye with the molecular formula c13h12i3n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3lgr5s8101, chemically known as 5-acetamido-2,4,6-triiodo-n-((methylcarbamoyl)methyl)isophthalamic acid but more generally known as ioglicic acid, which bears u.s. national institutes of health compound identifier 65437. the european medicines agency schedules ioglicic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08223mig. the term ioglicic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). the world health organization schedules ioglicic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(c(i)c(c(i)c1nc(=o)c)c(=o)o)c(=o)ncc(=o)nc. most nations schedule ioglicic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioglycamic acid. this classification denotes an iodinated contrast dye with the molecular formula c18h10i6n2o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier et36gpp4t7, chemically known as 3,3-(diglycoloyldiimino)bis(2,4,6-triiodobenzoic acid) but more generally known as ioglycamic acid, which bears u.s. national institutes of health compound identifier 17477. the european medicines agency schedules ioglycamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08227mig. the term ioglycamic acid is an international non-proprietary name. the world health organization schedules ioglycamic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(nc(=o)cocc(=o)nc2c(i)c(c(i)cc2i)c(=o)o)c(i)cc(i)c1c(=o)o. most nations schedule ioglycamic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iohexol. this classification denotes an iodinated contrast dye with the molecular formula c19h26i3n3o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4419t9mx03, chemically known as 1,3-benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-n,n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo but more generally known as iohexol, which bears u.s. national institutes of health compound identifier 3730. the european medicines agency schedules iohexol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08228mig. the term iohexol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 34, no. 10 1980, list 20). the world health organization schedules iohexol in its anatomical therapeutic chemical (atc) classification. iohexol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1c(n(cc(o)co)c(=o)c)c(i)c(c(i)c1c(=o)ncc(o)co)c(=o)ncc(o)co. most nations schedule iohexol under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iomeprol. this classification denotes an iopamidol analog and contrast media with the molecular formula c17h22i3n3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 17e17jbp8l, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)methylamino)-2,4,6-triiodo- but more generally known as iomeprol, which bears u.s. national institutes of health compound identifier 3731. the european medicines agency schedules iomeprol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08234mig. the world health organization schedules iomeprol in its anatomical therapeutic chemical (atc) classification. iomeprol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1c(n(c)c(=o)co)c(i)c(c(i)c1c(=o)ncc(o)co)c(=o)ncc(o)co. most nations schedule iomeprol under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iopamidol. this classification denotes an iodinated contrast dye, which practitioners deploy in magnetic resonance imaging (mri) and/or magnetic resonance spectroscopy (mrs), with the molecular formula c17h22i3n3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jr13w81h44, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo- but more generally known as iopamidol, which bears u.s. national institutes of health compound identifier 3734. the european medicines agency schedules iopamidol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08239mig. the term iopamidol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). the world health organization schedules iopamidol in its anatomical therapeutic chemical (atc) classification. iopamidol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1c(c(i)c(nc(=o)c(o)c)c(i)c1c(=o)nc(co)co)c(=o)nc(co)co. most nations schedule iopamidol under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iopanoic acid. this classification denotes an iodinated contrast dye, which practitioners use, as one example, in x-ray and/or computed tomography (ct) brain studies, with the molecular formula c11h12i3no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fe9794p71j, chemically known as 3-amino-alpha-ethyl-2,4,6-triiodohydrocinnamic acid but more generally known as iopanoic acid, which bears u.s. national institutes of health compound identifier 3735. the european medicines agency schedules iopanoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08240mig. the term iopanoic acid is an international non-proprietary name. the world health organization schedules iopanoic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule iopanoic acid under hs 29224995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iopentol. this classification denotes a triiodobenzoic acid and contrast media with the molecular formula c20h28i3n3o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7d6xwx076t, chemically known as 1,3-benzenedicarboxamide, 5-(acetyl(2-hydroxy-3-methoxypropyl)amino)-n,n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- but more generally known as iopentol, which bears u.s. national institutes of health compound identifier 56016. the european medicines agency schedules iopentol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08241mig. the world health organization schedules iopentol in its anatomical therapeutic chemical (atc) classification. iopentol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1c(n(cc(o)coc)c(=o)c)c(i)c(c(i)c1c(=o)ncc(o)co)c(=o)ncc(o)co. most nations schedule iopentol under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iophenoic acid or ioprocemic acid. this classification denotes a contrast agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 73tjc7jguy. the european medicines agency schedules iophenoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08242mig. iophenoic acid generally arises in the molecular formula c11h11i3o3. the term iophenoic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3.) smiles: ccc(cc1=c(c(=c(c=c1i)i)o)i)c(=o)o. most nations schedule iophenoic acid or ioprocemic acid under hs 29182980.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iopromide. this classification denotes an iodinated contrast dye with the molecular formula c18h24i3n3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 712bac33mz, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino)-n-methyl-2,4,6-triiodo- but more generally known as iopromide, which bears u.s. national institutes of health compound identifier 3736. the european medicines agency schedules iopromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08244mig. the term iopromide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 37, no. 6, 1983, list 23). the world health organization schedules iopromide in its anatomical therapeutic chemical (atc) classification. iopromide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1c(c(=o)n(cc(o)co)c)c(i)c(nc(=o)coc)c(i)c1c(=o)ncc(o)co. most nations schedule iopromide under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iopydol. this classification denotes an iodinated contrast dye with the molecular formula c8h9i2no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t4661k682a, chemically known as 4(1h)-pyridinone, 1-(2,3-dihydroxypropyl)-3,5-diiodo- but more generally known as iopydol, which bears u.s. national institutes of health compound identifier 21751. the european medicines agency schedules iopydol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08246mig. the term iopydol is an international non-proprietary name. the world health organization schedules iopydol in its anatomical therapeutic chemical (atc) classification. iopydol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1cn(cc(o)co)cc(i)c1=o. most nations schedule iopydol under hs 29333999.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iotalamic acid or iotalamate or sodium iotalamate. this classification denotes an iodinated contrast dye with the molecular formula c11h9i3n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 16chd79mix, chemically known as 5-acetamido-2,4,6-triiodo-n-methylisophthalamic acid but more generally known as iotalamic acid, which bears u.s. national institutes of health compound identifier 3737. the european medicines agency schedules iotalamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08254mig. the world health organization schedules iotalamic acid in its anatomical therapeutic chemical (atc) classification. smiles: cc(=o)nc1=c(c(=c(c(=c1i)c(=o)o)i)c(=o)nc)i. most nations schedule iotalamate or sodium iotalamate under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iotrolan. this classification denotes an iodinated contrast dye with the molecular formula c37h48i6n6o18, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 16fl47b687, chemically known as 5,5-(malonylbis(methylimino))bis(n,n-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodoisophthalamide) but more generally known as iotrolan, which bears u.s. national institutes of health compound identifier 3738. the european medicines agency schedules iotrolan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08260mig. the term iotrolan is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24). the world health organization schedules iotrolan in its anatomical therapeutic chemical (atc) classification. iotrolan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ic1c(c(=o)nc(c(o)co)co)c(i)c(n(c(=o)cc(=o)n(c2c(i)c(c(=o)nc(c(o)co)co)c(i)c(c(=o)nc(c(o)co)co)c2i)c)c)c(i)c1c(=o)nc(c(o)co)co. most nations schedule iotrolan under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. iotroxic acid. this classification denotes an iodinated contrast dye with the molecular formula c22h18i6n2o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84c5ptp9x6, chemically known as 3,3-(oxybis(ethyleneoxymethylenecarbonylimino))bis(2,4,6-triiodobenzoic acid) but more generally known as iotroxic acid, which bears u.s. national institutes of health compound identifier 3740. the european medicines agency schedules iotroxic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08261mig. the term iotroxic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). the world health organization schedules iotroxic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(nc(=o)coccoccocc(=o)nc2c(i)c(c(i)cc2i)c(=o)o)c(i)cc(i)c1c(=o)o. most nations schedule iotroxic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioxaglate or ioxaglate meglumine or ioxaglate sodium or sodium ioxaglate. this classification denotes an iodinated contrast dye with the molecular formula c24h20i6n5o8.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hq43cn02u9, chemically known as sodium n-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(n-methylacetamido)-5-(methylcarbamoyl)benzamido)acetamido)isophthalamate but more generally known as ioxaglate sodium, which bears u.s. national institutes of health compound identifier 50016. the european medicines agency schedules ioxaglate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02757mig. smiles: cc(=o)n(c)c1=c(c(=c(c(=c1i)c(=o)ncc(=o)nc2=c(c(=c(c(=c2i)c(=o)[o-])i)c(=o)ncco)i)i)c(=o)nc)i.[na+]. most nations schedule ioxaglate or ioxaglate meglumine or ioxaglate sodium or sodium ioxaglate under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioxaglic acid. this classification denotes an iodinated contrast dye with the molecular formula c24h21i6n5o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z40x7ei2af, chemically known as n-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(n-methylacetamido)-5-(methylcarbamoyl)benzamido)acetamido)isophthalamic acid but more generally known as ioxaglic acid, which bears u.s. national institutes of health compound identifier 3742. the european medicines agency schedules ioxaglic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08264mig. the term ioxaglic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17). the world health organization schedules ioxaglic acid in its anatomical therapeutic chemical (atc) classification. smiles: ic1c(n(c)c(=o)c)c(i)c(c(i)c1c(=o)ncc(=o)nc1c(i)c(c(i)c(c1i)c(=o)o)c(=o)ncco)c(=o)nc. most nations schedule ioxaglic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioxitalamic acid or ioxithalamic acid or ioxithalamate. this classification denotes an iodinated contrast dye with the molecular formula c12h11i3n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 967rdi7z6k, chemically known as 5-acetamido-n-(2-hydroxyethyl)-2,4,6-triiodoisophthalamic acid but more generally known as ioxitalamic acid, which bears u.s. national institutes of health compound identifier 34536. the european medicines agency schedules ioxitalamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08266mig. the term ioxitalamic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). the world health organization schedules ioxitalamic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule ioxitalamic acid or ioxithalamic acid or ioxithalamate under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. propyliodone. this classification denotes a contrast agent with the molecular formula c10h11i2no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5npj6bpx36, chemically known as 3,5-diiodo-4-pyridone-n-acetic acid propyl ester but more generally known as propyliodone, which bears u.s. national institutes of health compound identifier 4949. the european medicines agency schedules propyliodone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10122mig. the term propyliodone is an international non-proprietary name. the world health organization schedules propyliodone in its anatomical therapeutic chemical (atc) classification. propyliodone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cccoc(=o)cn1c=c(c(=o)c(=c1)i)i. most nations schedule propyliodone under hs 29333999.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. rose bengal sodium i 131. this classification denotes a dye with the molecular formula c20h2cl4i4o5.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 956575sn5l, chemically known as 4,5,6,7-tetrachloro-2,4,5,7-tetraiodofluorescein disodium salt but more generally known as rose bengal sodium, which bears u.s. national institutes of health compound identifier 69438. european medicines agency schedules rose bengal sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15149mig. world health organization schedules rose bengal sodium in its anatomical therapeutic chemical (atc) classification. smiles: c1=c2c(=c3c=c(c(=o)c(=c3oc2=c(c(=c1i)[o-])i)i)i)c4=c(c(=c(c(=c4cl)cl)cl)cl)c(=o)[o-].[na+].[na+].. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. sodium iodide i-123. this classification denotes a sodium iodide radioactive with the molecular formula i.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29ukx3a616. the term sodium iodide i 123 is a u.s. fda designation. as of q4 2014, sodium iodide i-123 remains the us fda preferred term for this commodity. sodium iodide i-123 bears us nlm identifiers umls id c0304977 and nci concept code c47724. smiles: [na+].[123i-].. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. sodium iodide i-131. this classification denotes a sodium iodide radioactive with the molecular formula nai, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29vco8achh, more generally known as sodium iodide i-131. european medicines agency schedules sodium iodide i-131 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12294mig. the term sodium iodide (131i) is an international non-proprietary name or inn. as of q4 2014, sodium iodide i-131 remains the us fda preferred term for this commodity. sodium iodide i-131 bears us nlm identifiers umls id c0304982 and nci concept code c47725. smiles: [na+].[i-].. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. sodium iopodate. this classification denotes a diagnostic reagent with the molecular formula c12h12i3n2o2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) f316llw9ww, chemically known as 2,4,6-triiodo-3-((dimethylaminomethylene)amino)hydrocinnamic acid but more generally known as ipodate sodium, which bears u.s. national institutes of health compound identifier 5241. european medicines agency schedules sodium iopodate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12441mig. the term sodium iopodate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules ipodate sodium in its anatomical therapeutic chemical (atc) classification. most nations schedule sodium iopodate under hs 29252900 and sitc 51482. smiles: cn(c)c=nc1=c(c=c(c(=c1i)ccc(=o)[o-])i)i.[na+].. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. sodium tyropanoate or tyropanoic acid. this classification denotes a contrast media with the molecular formula c15h18i3no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4f05v145yr, chemically known as 3-butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamic acid sodium salt but more generally known as tyropanoic acid, which bears u.s. national institutes of health compound identifier 23676. the european medicines agency schedules tyropanoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05028mig. the world health organization schedules tyropanoic acid in its anatomical therapeutic chemical (atc) classification. smiles: cccc(=o)nc1=c(c=c(c(=c1i)cc(cc)c(=o)[o-])i)i.[na+]. most nations schedule sodium tyropanoate or tyropanoic acid under hs 29242995.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioxilan. this classification denotes an iodinated contrast dye with the molecular formula c18h24i3n3o8, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier a4yj7j11tg, chemically known as 1,3-benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-n-(2,3-dihydroxypropyl)-n-(2-hydroxyethyl)-2,4,6-triiodo- but more generally known as ioxilan, which bears u.s. nih compound identifier 3743. european medicines agency schedules ioxilan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08265mig. the term ioxilan is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules ioxilan in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. ioxilan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"iodine-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with symbol i and atomic number 53, called iodine, and isotopes thereof, thus the term iodine-based medical imaging agents and media.. ioversol. this classification denotes an iodinated contrast dye with the molecular formula c18h24i3n3o9, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier n3rib7x24k, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)(2-hydroxyethyl)amino)-2,4,6-triiodo- but more generally known as ioversol, which bears u.s. national institutes of health compound identifier 3741. european medicines agency schedules ioversol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08262mig. the term ioversol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules ioversol in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. ioversol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"manganese-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes particle- or wave-sensitive substances that practitioners use in to enhance visualization of bodily fluids, structures, and/or tissue, or otherwise, as biological indicators in diagnosis of disease, substances that are commonly called agents, media, or tracers, and which are also compounds based in part or whole on manganese, which practitioners use chiefly in magnetic resonance imaging (mri) and/or magnetic resonance spectroscopy (mrs), thus the term manganese-based radiopharmaceuticals, imaging agents, media, and tracers. practitioners most often use such manganese-based radiopharmaceuticals, imaging agents, media, and tracers in the following studies and therapies: alzheimers disease, atherosclerosis, blood pool contrast studies, carotid artery injury, cell tracking, cellular mri, gastrointestinal imaging (as an oral agent), hepatic vascularature, hepatobiliary imaging, liver, macrophages, malignant mesothelioma detection, myocardial ischemia, myocardial perfusion, tumor angiogenesis, tumor detection and imaging, and tumor scintigraphy/therapy.. . "
"manganese-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes particle- or wave-sensitive substances that practitioners use in to enhance visualization of bodily fluids, structures, and/or tissue, or otherwise, as biological indicators in diagnosis of disease, substances that are commonly called agents, media, or tracers, and which are also compounds based in part or whole on manganese, which practitioners use chiefly in magnetic resonance imaging (mri) and/or magnetic resonance spectroscopy (mrs), thus the term manganese-based radiopharmaceuticals, imaging agents, media, and tracers. practitioners most often use such manganese-based radiopharmaceuticals, imaging agents, media, and tracers in the following studies and therapies: alzheimers disease, atherosclerosis, blood pool contrast studies, carotid artery injury, cell tracking, cellular mri, gastrointestinal imaging (as an oral agent), hepatic vascularature, hepatobiliary imaging, liver, macrophages, malignant mesothelioma detection, myocardial ischemia, myocardial perfusion, tumor angiogenesis, tumor detection and imaging, and tumor scintigraphy/therapy.. mangafodipir. this classification denotes a contrast media c22h26n4o14p2.h+.mn.3na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 129fw80tg4, chemically known as mangafodipir trisodium, anhydrous, but more generally known as mangafodipir trisodium, which bears u.s. national institutes of health compound identifier 160036. european medicines agency schedules sub12529migin its extended eudravigilance medicinal product dictionary or xevmpd under index sub12529mig. most nations schedule mangafodipir trisodium under hs 29333999 and sitc 51574. mangafodipir trisodium bears us nlm identifiers umls id c0067297 and nci concept code c66053. smiles: as of q4 2014, mangafodipir trisodium remains the us fda preferred term for this commodity.. "
"sodium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with the symbol na, called sodium, and isotopes thereof, thus the term sodium-based radiopharmaceuticals, imaging agents, media, and tracers.. . "
"sodium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with the symbol na, called sodium, and isotopes thereof, thus the term sodium-based radiopharmaceuticals, imaging agents, media, and tracers.. indigo carmine or indigotindisulfonate sodium. this classification denotes a dye with the molecular formula c16h8n2o8s2.2na, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier d3741u8k7l, chemically known as 2-(1,3-dihydro-3-oxo-5-sulfo-2h-indol-2-ylidene)-2,3-dihydro-3-oxo-1h-indole-5-sulfonic acid, disodium salt but more generally known as acid blue 74, which bears us nih compound identifier 5282429. european medicines agency schedules indigo carmine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12518mig world health organization schedules acid blue 74 in its anatomical therapeutic chemical (atc) classification. indigotindisulfonate sodium bears us nlm identifiers umls id c0021219 and nci concept code c83799. smiles: s(=o)(=o)(o)c1cc2c(n/c(=c3/nc4c(c3=o)cc(s(=o)(=o)o)cc4)c2=o)cc1.[na].[na].. "
"sodium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with the symbol na, called sodium, and isotopes thereof, thus the term sodium-based radiopharmaceuticals, imaging agents, media, and tracers.. phenolsulfonphthalein. this classification denotes a diagnostic reagent with the molecular formula c19h14o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i6g9y0j1oj, chemically known as 4,4-(3h-2,1-benzoxathiol-3-ylidene)diphenol s,s-dioxide but more generally known as phenolsulfonphthalein, which bears us nih compound identifier 4766. the european medicines agency schedules phenolsulfonphthalein in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14835mig. the world health organization schedules phenolsulfonphthalein in its anatomical therapeutic chemical (atc) classification.. "
"sodium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with the symbol na, called sodium, and isotopes thereof, thus the term sodium-based radiopharmaceuticals, imaging agents, media, and tracers.. sulfobromophthalein sodium. this classification denotes a dye with the molecular formula c20h8br4o10s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 62e5ju30ov, chemically known as 4,5,6,7-tetrabromo-3,3-disulfophenolphthalein disodium salt but more generally known as sulfobromophthalein sodium, which bears u.s. national institutes of health compound identifier 6282.. "
"sodium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with the symbol na, called sodium, and isotopes thereof, thus the term sodium-based radiopharmaceuticals, imaging agents, media, and tracers.. sulfobromophthalein. this classification denotes a dye with the molecular formula c20h10br4o10s2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 0c2p5qkl36, chemically known as 3,3-(4,5,6,7-tetrabromo-3-oxo-1(3h)-isobenzofuranylidene)bis(6-hydroxybenzenesulphonic) acid but more generally known as sulfobromophthalein, which bears u.s. nih compound identifier 5345. world health organization schedules sulfobromophthalein in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. . "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m apcitide or technetium 99mtc apcitide. this classification denotes a radioconjugate with the molecular formula c51h72n17o19s5.tco.na.h, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier iv7t84qa4t, more generally known as technetium tc 99m apcitide. the european medicines agency schedules technetium tc 99m apcitide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10860mig. the term technetium tc-99m apcitide is an international non-proprietary name or inn. most nations schedule technetium tc-99m apcitide or technetium 99mtc apcitide under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m arcitumomab or technetium 99mtc arcitumomab. this classification denotes a radioconjugate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 029jf1scu8, more generally known as technetium tc 99m arcitumomab. the european medicines agency schedules technetium tc 99m arcitumomab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00571mig. the term technetium tc-99m arcitumomab is an international non-proprietary name or inn. most nations schedule technetium tc-99m arcitumomab or technetium 99mtc arcitumomab under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m bicisate or technetium 99mtc bicisate. this classification denotes a radioconjugate with the molecular formula c12h21n2o4s2.tco, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h25wja31xe, more generally known as technetium tc 99m bicisate. the european medicines agency schedules technetium tc 99m bicisate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15462mig. the term technetium tc 99m bicisate is an international non-proprietary name or inn. most nations schedule technetium tc-99m bicisate or technetium 99mtc bicisate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m disofenin or technetium 99mtc disofenin. this classification denotes a radioconjugate, a contrast agent that practitioners use in cholescintigraphy and ultrasonography, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qtj2viw97t. the european medicines agency schedules technetium tc 99m disofenin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15465mig. technetium tc 99m disofenin generally arises in the molecular formula c18h26n2o5.tc. the term technetium tc 99m disofenin is a u.s. fda orange book designation. most nations schedule technetium tc-99m disofenin or technetium 99mtc disofenin under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m fanolesomab or technetium 99mtc fanolesomab. this classification denotes a radioconjugate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier amf7koe318, more generally known as technetium tc 99m fanolesomab. the european medicines agency schedules technetium tc 99m fanolesomab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27898. the term technetium tc-99m fanolesomab is an international non-proprietary name or inn. most nations schedule technetium tc-99m fanolesomab or technetium 99mtc fanolesomab under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m furifosmin or technetium 99mtc furifosmin. this classification denotes a radioconjugate known as technetium tc 99m furifosmin. the european medicines agency schedules technetium tc 99m furifosmin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10861mig. the term technetium tc-99m furifosmin is an international non-proprietary name or inn. most nations schedule technetium tc-99m furifosmin or technetium 99mtc furifosmin under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m gluceptate or technetium 99mtc gluceptate. this classification denotes a radioconjugate, an contrast medium is study ntracranial lesions, cerebral disorders, and renal disorders, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i853le095b. the european medicines agency schedules technetium tc 99m gluceptate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15469mig. technetium tc 99m gluceptate generally arises in the molecular formula c7h14o8.tc. the term technetium tc-99m gluceptate is a u.s. fda orange book designation. most nations schedule technetium tc-99m gluceptate or technetium 99mtc gluceptate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m mebrofenin or technetium 99mtc mebrofenin. this classification denotes a radioconjugate, a a hepatobiliary imaging agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f2nq468l52. the european medicines agency schedules technetium tc 99m mebrofenin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15472mig. technetium tc 99m mebrofenin generally arises in the molecular formula c15h19brn2o5.tc. the term technetium tc-99m mebrofenin is a u.s. fda orange book designation. most nations schedule technetium tc-99m mebrofenin or technetium 99mtc mebrofenin under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m medronate or technetium 99mtc medronate. this classification denotes a radioconjugate, a bone imaging agent that practitioners use to delineate areas of altered osteogenesis, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x89xv46r07. the european medicines agency schedules technetium tc 99m medronate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15473mig. technetium tc 99m medronate generally arises in the molecular formula ch2o6p2.tc. the term technetium tc-99m medronate is a u.s. fda orange book designation. most nations schedule technetium tc-99m medronate or technetium 99mtc medronate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m mertiatide or technetium 99mtc mertiatide. this classification denotes a radioconjugate with the molecular formula c8h8n3o5s.2na.o.tc, often used in study renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 36ito9skqj. the term technetium (sup 99m)tc mertiatide is a u.s. fda designation. most nations schedule technetium tc-99m mertiatide or technetium 99mtc mertiatide under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m nofetumomab merpentan or technetium 99mtc nofetumomab merpentan. this classification denotes a radioconjugate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ufh75ht7s, more generally known as technetium tc 99m nofetumomab merpentan. most nations schedule technetium tc-99m nofetumomab merpentan or technetium 99mtc nofetumomab merpentan under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m pentetate or technetium 99mtc pentetate. this classification denotes a radioconjugate with the molecular formula c14h18n3o10.na.tc, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vw78417pu1, chemically known as technetate(1-)(sup 99 m)tc, (n,n-bis(2-bis(carboxymethyl)amino)ethyl)glycinato(5-))-, sodium but more generally known as technetium tc 99m pentetate, which bears u.s. national institutes of health compound identifier 6328391. the european medicines agency schedules technetium tc 99m pentetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15476mig. in general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer. this commodity aids in renal imaging. most nations schedule technetium tc-99m pentetate or technetium 99mtc pentetate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m pertechnetate or technetium 99mtc pertechnetate. this classification denotes a radioconjugate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ppp8783iq1, more generally known as technetium tc 99m pertechnetate. the european medicines agency schedules technetium tc 99m pertechnetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20433. the term technetium tc-99m pertechnetate is an international non-proprietary name or inn. most nations schedule technetium tc-99m pertechnetate or technetium 99mtc pertechnetate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m pintumomab or technetium 99mtc pintumomab. this classification denotes a radioconjugate, generally known as technetium tc 99m pintumomab. the european medicines agency schedules technetium tc 99m pintumomab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27896. the term technetium tc-99m pintumomab is an international non-proprietary name or inn. most nations schedule technetium tc-99m pintumomab or technetium 99mtc pintumomab under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m pyrophosphate or technetium 99mtc pyrophosphate. this classification denotes a radioconjugate, a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5l76i61h2b. the european medicines agency schedules technetium tc 99m pyrophosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25767. technetium tc-99m pyrophosphate generally arises in the molecular formula tc.h4o7p2. the term technetium tc 99m pyrophosphate is a u.s. fda orange book designation. most nations schedule technetium tc-99m pyrophosphate or technetium 99mtc pyrophosphate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m sestamibi or technetium 99mtc sestamibi. this classification denotes a radioconjugate with the molecular formula c36h66n6o6tc, a contrast medium that practitioners use in myocardial perfusion studies, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 971z4w1s09, more generally known as technetium tc-99m sestamibi. the european medicines agency schedules technetium tc 99m sestamibi in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10857mig. the term technetium tc 99m sestamibi is an international non-proprietary name or inn. most nations schedule technetium tc-99m sestamibi or technetium 99mtc sestamibi under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m sodium pertechnetate or technetium 99mtc sodium pertechnetate. this classification denotes a radioconjugate with the molecular formula na.o4tc, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a0730cx801. the term sodium pertechnetate (sup 99m)tc is a u.s. fda designation. most nations schedule technetium tc-99m sodium pertechnetate or technetium 99mtc sodium pertechnetate under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m succimer or technetium 99mtc succimer. this classification denotes a radioconjugate with the molecular formula c4h6o4s2.tc, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 494jnq8l28. the term technetium tc-99m succimer is a u.s. fda designation. most nations schedule technetium tc-99m succimer or technetium 99mtc succimer under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m sulfur colloid or technetium 99mtc sulfur colloid. this classification denotes a contrast media, commonly used in lymphoscintigraphy (on breast cancer patients, and for liver, spleen and bone marrow imaging and gastric transit studies and gastroesophageal reflux), a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 556q0p6pb1. the european medicines agency schedules technetium tc 99m sulfur colloid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12345mig. technetium tc 99m sulfur colloid generally arises in the molecular formula s8.tc. the term technetium tc-99m sulfur colloid is a hazardous substances data bank designation. most nations schedule technetium tc-99m sulfur colloid or technetium 99mtc sulfur colloid under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m teboroxime or technetium 99mtc teboroxime. this classification denotes a radioconjugate with the molecular formula (c6h9n2o2)2./c6h8n2o2.tc,cl,ch3,b, a cardiac imaging contrast medium most often used in myocardial perfusion imaging, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ut0whj4951, more generally known as technetium tc 99m teboroxime. in general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer. the european medicines agency schedules technetium tc 99m teboroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04709mig. the term technetium tc-99m teboroxime is an international non-proprietary name or inn. most nations schedule technetium tc-99m teboroxime or technetium 99mtc teboroxime under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m tetrofosmin or technetium 99mtc tetrofosmin. this classification denotes a radioconjugate with the molecular formula (c6h9n2o2)2./c6h8n2o2.tc,cl,ch3,b, a cardiac imaging contrast medium most often used in myocardial perfusion imaging, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ut0whj4951, more generally known as technetium tc 99m teboroxime. in general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer. the european medicines agency schedules technetium tc 99m teboroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04709mig. the term technetium tc-99m teboroxime is an international non-proprietary name or inn. most nations schedule technetium tc-99m tetrofosmin or technetium 99mtc tetrofosmin under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m tilmanocept or technetium 99mtc tilmanocept. this classification denotes a radioconjugate, generally known as technetium tc 99m tilmanocept. the term technetium tc-99m tilmanocept is an international non-proprietary name or inn. in general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer. this commodity aids in lymphatic studies. most nations schedule technetium tc-99m tilmanocept or technetium 99mtc tilmanocept under hs 28444030.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m lidofenin. this classification denotes a radioconjugate that world health organization schedules in its anatomical therapeutic chemical (atc) classification, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6433tzj6tq. smiles: cc1cccc(c1nc(=o)cn(cc(=o)[o-])cc(=o)[o-])c.[o-2].[tc+4]. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m phytate. this classification denotes a radioconjugate that world health organization schedules in its anatomical therapeutic chemical (atc) classification.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m sulesomab. this classification denotes a technetium radioconjugate that practitioners use in bone and soft tissue scans, most especially to isolate prosthetic joint infection (with technetium tc-99m sulesomab or sulesomab and tc-labeled leukocytes). world health organization schedules in its anatomical therapeutic chemical (atc) classification.. "
"technetium-based radiopharmaceuticals, imaging agents, media, and tracers. this classification denotes a variety of compounds and preparations that are sensitive to frequencies or rays common in nuclear medicine that empower practitioners to differentiate between cell or tissue types, or to bring to focus one cell or tissue type over another, and to thus examine internal body parts or systems, typically for diagnostic purposes, and which are based in part or whole on the chemical element with atomic number 43 and the symbol tc, called technetium, and isotopes thereof, thus the term technetium-based radiopharmaceuticals, imaging agents, media, and tracers.. technetium tc-99m tin colloid. this classification denotes a technetium radioconjugate that world health organization schedules in its anatomical therapeutic chemical (atc) classification.. "
